We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The raging COVID-19 pandemic has not only confirmed how interdependent the global pharmaceutical industry is but also exposed the danger in Africa’s heavy reliance on pharmaceutical product imports hence mounting pressure on governments in the region.
The Government announced Production Linked Incentive(PLI) Scheme for Bulk Drugs and Medical Devices have shown a very encouraging response from the pharmaceutical as well as the medical device industry.